Skip to main content
. 2015 Jun 8;36(8):998–1012. doi: 10.1038/aps.2015.17

Table 6. The molecular interactions between the compounds and AKR1B10 protein.

Compound Hydrogen bond interaction
Hydrophobic interaction
Ligand atom Amino acid Amino acid atom Length (Å)
Inhibitora O23 Lys22 HZ3 2.336 Val48, Gln50, His111, Trp112, Phe123, Cys299, Val301, Leu302
O24 Tyr49 OH 2.446
O24 Lys78 HZ2 1.939
Hit 1 O28 Lys22 HZ3 2.317 Val48, Trp80, His111, Trp112, Phe123, Asn161, Pro219, Trp220, Cys299, Val301, Leu302
O28 Gln50 HE21 2.051
H50 Tyr49 O 2.330
O27 Lys125 HZ1 1.988
Hit 2 H44 Tyr49 OH 2.442 Trp21, Ala46, Val48, Lys78, Trp80, His111, Trp112, Phe123, Asn161, Trp220, Leu302
O11 Cys299 HG 2.021
O11 Val301 HN 2.494
Hit 3 O23 Lys22 HZ2 2.482 Trp21, Tyr49, Trp80, Trp112, Phe123, Pro219, Trp220, Val301, Leu302
H42 Val48 O 1.474
HE21 Gln50 O24 2.051
H32 His111 NE2 1.676

a Reference inhibitor; the most active compound in the training set, 7-hydroxy-2-(4-methoxyphenylimino)-2H-chromene-3-carboxylic acid benzylamide.